Company Profile
Bayer CropScience Limited, together with its subsidiaries, engages in the agriculture business in India, Germany, Bangladesh, and internationally. The company manufactures, sells, and distributes agrochemical products, including insecticides, fungicides, herbicides, seed treatment solutions, and biologicals; produces, sells, and distributes hybrid corn seeds, as well as rice, fruits, and vegetables; and integrates digital farming solutions, such as remote sensing, artificial intelligence, IoT, drones, and data analytics. It also offers medicines for various therapeutic areas comprising cardiology, diabetes, kidney health, women's health, oncology, ophthalmology, and radiology; and over-the-counter products, which include analgesics, nutrition, allergy, dermatology, and digestives. The company exports its products. Bayer CropScience Limited was founded in 1863 and is based in Thane, India.
Latest News
How Lisa Su Has Positioned AMD to Be a Big AI Winner and Why the Stock Is a Buy
Share buybacks in Ericsson during the period July 20 - July 24, 2026
OTLK Stock Jumps Overnight After FDA Approval Of Wet AMD Drug — Analysts See Nearly 300% Upside
Temenos Named One of World’s Top Fintech Companies by CNBC
Emerging markets stare at inflation risks as powerful El Niño looms
| Sector | Basic Materials |
| Industry | Agricultural Inputs |
| Website | https://www.bayer.in |
| Market Cap | 190.35B |
| Trailing P/E | 27.58 |
| Forward P/E | 21.94 |
| Dividend Rate | 120 |
| Dividend Yield | 2.84% |
| Trailing Annual Div. Rate | 150 |
| Trailing Annual Div. Yield | 3.56% |
| Trailing EPS | 153.55 |
| Forward EPS | 193.05 |
| Book Value | 659.89 |
| Price-to-Book | 6.42 |
| Enterprise-to-Revenue | 3.1 |
| Enterprise-to-EBITDA | 21.48 |
| Ex-Dividend Date | 08/04/2026 |
| Earnings Date | 08/05/2026 |
| Earnings Call Date | |
| Earnings Average | 60.45 |
| Earnings Low | 57.3 |
| Earnings High | 63.6 |
| Revenue Average | 18.35B |
| Revenue Low | 17.54B |
| Revenue High | 20.30B |